Logo Intrado.png
Hyloris Provides Additional Information on U.S. FDA Review of NDA Application for the Registration of Maxigesic IV®
July 01, 2022 14:00 ET | Hyloris Pharmaceuticals SA
FDA did not report any issues with clinical dataHyloris is asked to submit a report describing potential extractable and leachable compounds expected to be present in the drug product based on the...
Bekaert: Publication transparency notification
July 01, 2022 12:00 ET | Bekaert
Please find herewith the press release. Attachment p220701E - Publication transparency notification ...
Bekaert: Openbaarmaking transparantiekennisgeving
July 01, 2022 12:00 ET | Bekaert
Gelieve in bijlage het persbericht te vinden. Bijlage p220701N - Openbaarmaking transparantiekenniswetgeving ...
Bekaert: Publication notification de transparence
July 01, 2022 12:00 ET | Bekaert
Veuillez trouver en annexe le communiqué de presse. Pièce jointe p220701F - Publication notification de transparence ...
Announcement of the total number of voting rights as at 30 June 2022
July 01, 2022 11:40 ET | KBC Ancora
Regulated information, Leuven, 1 July 2022 (17.40 hrs CEST) Announcement of the total number of voting rights as at 30 June 2022 In application of Article 15 of the Act of 2 May 2007 on the...
Bekendmaking van het totaal aantal stemrechten per 30 juni 2022
July 01, 2022 11:40 ET | KBC Ancora
Gereglementeerde informatie, Leuven, 1 juli 2022 (17.40 CEST) Bekendmaking van het totaal aantal stemrechten per 30 juni 2022 In toepassing van artikel 15 van de wet van 2 mei 2007 op de...
Annonce du nombre total des droits de vote au 30 juin 2022
July 01, 2022 11:40 ET | KBC Ancora
Information réglementée, Leuven, 1er juillet 2022 (17.40 CEST) Annonce du nombre total des droits de vote au 30 juin 2022 En application de l'article 15 de la loi du 2 mai 2007 relative à la...
Logo Intrado.png
US FDA seeks more information on Maxigesic IV® application
July 01, 2022 03:55 ET | Hyloris Pharmaceuticals SA
US FDA seeks more information on Maxigesic IV® application For Immediate release Liège, Belgium – 01 July 2022 - Regulted information - Inside Information - Hyloris Pharmaceuticals SA (Euronext...
Disposal of own shares by Bekaert
July 01, 2022 02:15 ET | Bekaert
Disposal of own shares by BekaertPublication in accordance with Article 8:6, § 1 of the Royal Decree of 29 April 2019 implementing the Code on Companies and Associations In May 2022, NV Bekaert SA...
Vervreemding van eigen aandelen door Bekaert
July 01, 2022 02:15 ET | Bekaert
Vervreemding van eigen aandelen door BekaertOpenbaarmaking conform artikel 8:6, § 1 van het koninklijk besluit van 29 april 2019 tot uitvoering van het Wetboek van vennootschappen en verenigingen In...